Table III.
Type | Description | Characteristics | Percentage |
---|---|---|---|
I | NEAME | Immunohistochemistry (+)Metastasis (−) | 76 % |
II | MEA | Immunohistochemistry (−)Metastasis (−) | 20 % |
III | CTME | Immunohistochemistry (+)Metastasis (+)and / or Carcinoid syndrome (+) | 4 % |